C-Bond Systems, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

Shareholders' Deficit (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Schedule of activity related to non-vested shares

		Number of Non-Vested Shares				Weighted Average Grant Date Fair Value
Non-vested, December 31, 2022			16,970,120			$	0.119
Granted			-				-
Shares vested			-				-
Non-vested, March 31, 2023			16,970,120			$	0.119

Schedule of stock option activities

		Number of Options				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Balance Outstanding, December 31, 2022			8,445,698			$	0.40				3.43				-
Exercised			-				-				-				-
Balance Outstanding, March 31, 2023			8,445,698			$	0.40				3.18			$	-
Exercisable, March 31, 2023			8,445,698			$	0.40				3.18			$	-

Schedule of warrant activities

		Number of Warrants				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Balance Outstanding December 31, 2022			34,000,000			$	0.011				3.73			$	-
Granted			-				-				-				-
Balance Outstanding March 31, 2023			34,000,000			$	0.011				3.48			$	-
Exercisable, March 31, 2023			34,000,000			$	0.011				3.48			$	-